针刺对慢性阻塞性肺疾病患者的多中心随机对照试验
该多中心开放标签随机对照试验纳入150例COPD患者,按1:1:1分为针刺组、常规药物组和针刺加常规药物组,治疗12周并随访12周。结果显示针刺加常规药物组在改善运动能力和生活质量、减轻呼吸困难方面优于其他两组,且安全性良好。
要点
- 针刺联合常规药物可显著提高COPD稳定期患者的6分钟步行距离。
- 联合治疗在改善生活质量(SGRQ)和呼吸困难(mMRC、CAT)方面优于单用。
- 针刺联合常规药物安全性良好,可作为COPD稳定期的辅助治疗。
核心结论
- 与针刺组和常规药物组相比,针刺加常规药物组在改善运动能力、生活质量和减轻呼吸困难方面更优。
- 针刺联合常规药物对COPD稳定期安全有效,可为后续研究提供参考。
研究设计与样本
- 多中心、开放标签、中央随机对照试验,纳入150例COPD患者,按1:1:1随机分为针刺组、常规药物组和针刺加常规药物组。
- 治疗12周,随后12周无治疗随访。
主要发现
- 三组在6分钟步行距离(6MWD)、SGRQ各维度及总分、急性加重次数、FEV1、FEV1/FVC、mMRC、CAT等指标上存在时间效应(P < 0.05)。
- 针刺加常规药物组在治疗第4、8、12周及随访第12周时6MWD较常规药物组显著增加(P < 0.05)。
- SGRQ症状、活动、影响及总分随时间变化(时间效应P < 0.05),但无组间效应或交互效应(P > 0.05)。
- mMRC存在时间和组间效应(P < 0.05),CAT存在时间、组间和交互效应(P < 0.05)。
临床怎么用
- 对于COPD稳定期患者,可考虑在常规药物治疗基础上联合针刺以改善运动耐量和呼吸困难。
- 针刺联合常规药物安全性良好,可作为综合管理的一部分。
局限性
- 原文未明确报告盲法实施细节及具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a common and frequently occurring disease that seriously endangers health, causing a heavy economic burden on patients and society. Acupuncture has been reported to have a therapeutic effect on patients with chronic obstructive pulmonary disease (COPD). However, compared with medications, it is difficult to identify a superior therapy. Therefore, the aim of this study was to evaluate the efficacy and safety of acupuncture, conventional drug and acupuncture plus conventional drug in the treatment of COPD. METHODS: This was a multicenter, open-label randomized controlled trial (RCT) through a central randomization system. A total of 150 COPD patients were randomly assigned at a 1:1:1 ratio to the acupuncture group, conventional drug group or acupuncture plus conventional drug group for 12 weeks of treatment, followed by 12 weeks of untreated follow-up. The primary outcomes included the six-minute walk distance (6MWD) and St. George's Respiratory Questionnaire (SGRQ), and the secondary outcomes included the modified Medical Research Council dyspnea scale (mMRC), acute exacerbation, lung function, and quality of life (COPD assessment test). Statistical analysis was conducted via SPSS software (version 26.0). RESULTS: A total of 150 patients were included in the study, and 143 patients completed the trial. There were time effects, group effects and interaction effects in the three groups (P < 0.05). Compared with that in the conventional drug group, the 6MWD in the acupuncture plus conventional drug group increased significantly at 4, 8, and 12 weeks of treatment and at 12 weeks of follow-up. The difference was statistically significant (P < 0.05). The symptom scores, motor scores, impact scores and total SGRQ scores at different time points in the three groups tended to change with time, with a time effect (P < 0.05), and there was no group or interaction effect (P > 0.05). Among the secondary outcomes, there were time effects on the number of acute exacerbations, forced expiratory volume in one second (FEV1) and forced expiratory volume in one second/forced vital capacity (FEV1/FVC) at different time points in the three groups (P < 0.05). mMRC had time and group effects (P < 0.05). CAT had time effects, group effects and interaction effects (P < 0.05). CONCLUSIONS: Compared with the acupuncture group and the conventional drug group, the acupuncture plus conventional drug group was better at improving exercise ability, improving quality of life, and reducing dyspnea. It is safe and effective for the treatment of chronic obstructive pulmonary disease in the stable period, which can provide a reference for further related research. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03169504. Registered on 30 May 2017.
引用
- Li J, Xie Y, Wang Y, et al. Effect of acupuncture on patients with chronic obstructive pulmonary disease: A multicenter randomized controlled trial. Complement Ther Med. 2025. PMID: 39956529. doi:10.1016/j.ctim.2025.103146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。